Please download the dossier by clicking on the dossier button x
×

Recurrent gene fusions in prostate cancer

  • US 20090208937A1
  • Filed: 07/06/2007
  • Published: 08/20/2009
  • Est. Priority Date: 09/12/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method for identifying prostate cancer in a patient comprising:

  • (a) providing a sample from the patient; and

    (b) detecting the presence or absence in the sample of a gene fusion having a 5′

    portion from a transcriptional regulatory region of an androgen regulated gene defined as SLC45A3, HERV-K

    22q1.23 or C15ORF21 and a 3′

    portion from an ETS family member gene,wherein detecting the presence in the sample of the gene fusion is indicative of identifies prostate cancer in the patient.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×